| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.4B | $8.6B | $8.7B | $9.3B | $8.4B | $7.4B | $3.2B | $3.0B |
| Cost of Revenue | $0.0B | $0.0B | $0.1B | $0.2B | $0.2B | $0.3B | $4.0B | $4.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.1B | $2.0B | $1.8B | $1.6B | $1.4B | $1.0B | $0.3B | $0.2B |
| Net Income | $1.1B | $1.0B | $0.9B | $1.1B | $1.5B | $-0.8B | $0.8B | $0.4B |
| EPS (Basic) | $1.61 | $1.58 | $1.37 | $1.60 | $2.35 | $-1.79 | $0.25 | $0.18 |
| EPS (Diluted) | $1.60 | $1.58 | $1.37 | $1.59 | $2.28 | $-1.79 | $0.25 | $0.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $46.5B | $43.8B | $39.7B | $38.5B | $37.7B | $33.5B | $35.4B | $27.0B |
| Current Assets | $5.7B | $4.4B | $3.0B | $4.7B | $7.4B | $2.9B | $3.8B | $7.0B |
| Cash & Equivalents | $0.0B | $0.0B | $0.1B | $0.1B | $0.2B | $0.1B | $0.2B | $4.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.3B | $4.0B | $3.9B | $5.1B | $4.3B | $4.8B | $3.9B | $3.3B |
| Stockholders' Equity | $11.2B | $10.7B | $9.7B | $10.0B | $9.4B | $8.3B | $8.4B | $8.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.1B | $3.9B | $1.8B | $0.0B | $2.0B | $1.6B | $2.1B |
| Investing Cash Flow | $-4.0B | $-4.5B | $-4.2B | $-1.6B | $-1.9B | $-1.3B | $-8.4B | $-1.2B |
| Capital Expenditures | $4.9B | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.5B | $2.3B | $0.4B | $-0.3B | $1.9B | $-0.8B | $2.8B | $3.1B |